Founded in 2007 and based in Jerusalem, Shavit Capital focuses on investing in Israeli companies with proven technologies, products, markets, and strong management teams. The firm has a particular interest in companies involved in cannabis medical products, cancer treatments, biopharmaceuticals, stem cell therapy, and generic drugs. They typically invest during private equity rounds and seek to be a lead investor. With over $200 million under management across four separate private equity funds, Shavit Capital looks for investment opportunities in successful, growing companies with a clear path to an IPO or public listing.